Profusa Inc(PFSA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PFSA Profusa Inc

休市中 08-21 16:00:00 EDT

5.46

-2.11

-27.87%

盘后5.47

+0.01+0.11%

19:59 EDT

最高7.54	最低5.28	成交量64.77万
今开6.65	昨收7.57	日振幅29.81%
总市值289.38万	流通市值289.38万	总股本53.00万
成交额409.97万	换手率122.21%	流通股本53.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PFSA","market":"US","secType":"STK","nameCN":"Profusa Inc","latestPrice":5.46,"timestamp":1787342400000,"preClose":7.57,"halted":0,"volume":647694,"hourTrading":{"tag":"盘后","latestPrice":5.4662,"preClose":5.46,"latestTime":"19:59 EDT","volume":37079,"amount":203973.9142,"timestamp":1787356798552,"change":0.0062,"changeRate":0.001136,"amplitude":0.069689},"delay":0,"changeRate":-0.2787318361955086,"floatShares":530000,"shares":530000,"eps":-1218.2388,"marketStatus":"休市中","change":-2.11,"latestTime":"08-21 16:00:00 EDT","open":6.65,"high":7.5365,"low":5.2801,"amount":4099660.13475,"amplitude":0.298071,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1218.2388,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":7.57,"preHourTrading":{"tag":"盘前","latestPrice":6.5799,"preClose":7.57,"latestTime":"09:29 EDT","volume":30261,"amount":204559.730067,"timestamp":1787318994632,"change":-0.9901,"changeRate":-0.130793,"amplitude":0.157199},"postHourTrading":{"tag":"盘后","latestPrice":5.4662,"preClose":5.46,"latestTime":"19:59 EDT","volume":37079,"amount":203973.9142,"timestamp":1787356798552,"change":0.0062,"changeRate":0.001136,"amplitude":0.069689},"volumeRatio":0.0542352876681745},"requestUrl":"/m/hq/s/PFSA","defaultTab":"news","newsList":[{"id":"1194929796","title":"Profusa公布2026年第二季度财务业绩及与商业化诊断公司G3 Vision Labs期权协议交割条件的最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1194929796","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194929796?lang=zh_cn&edition=full","pubTime":"2026-08-20 20:32","pubTimestamp":1787229149,"startTime":"0","endTime":"0","summary":"Profusa Inc今日正式披露其2026年第二季度财务报告，同时就与G3 Vision Labs——一家已步入商业化阶段的诊断企业——所签署期权协议的交割条件，公布了阶段性进展详情。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PFSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162367186","title":"Profusa 宣布管理层重大调整，并签署收购商业化诊断公司非约束性条款清单","url":"https://stock-news.laohu8.com/highlight/detail?id=1162367186","media":"美股速递","labels":["executive","corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162367186?lang=zh_cn&edition=full","pubTime":"2026-07-27 18:01","pubTimestamp":1785146471,"startTime":"0","endTime":"0","summary":"Profusa Inc 今日宣布，公司管理层将迎来关键性变动。与此同时，该公司还披露，已就收购一家处于商业化阶段的体外诊断公司，正式签署了非约束性条款清单。（Profusa Inc）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive,corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PFSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144128710","title":"Profusa：因1比25并股，售股股东转售普通股数量由1.7927亿股减至717万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1144128710","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144128710?lang=zh_cn&edition=full","pubTime":"2026-07-07 21:05","pubTimestamp":1783429534,"startTime":"0","endTime":"0","summary":"Profusa公司宣布，由于实施了1比25的反向股票分割，售股股东计划转售的普通股数量已从原先的1.7927亿股大幅减少至717万股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142757758","title":"Profusa公司提交SEC文件：售股股东拟不时发售及转售最多717万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1142757758","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142757758?lang=zh_cn&edition=full","pubTime":"2026-07-07 20:45","pubTimestamp":1783428340,"startTime":"0","endTime":"0","summary":"Profusa公司已向美国证券交易委员会提交文件，披露售股股东计划在特定时期内，不时提供并转售最多达717万股的公司普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127970640","title":"Profusa宣布1比25反向股票分割","url":"https://stock-news.laohu8.com/highlight/detail?id=1127970640","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127970640?lang=zh_cn&edition=full","pubTime":"2026-07-07 16:51","pubTimestamp":1783414294,"startTime":"0","endTime":"0","summary":"Profusa Inc宣布，将对其普通股实施1比25的反向股票分割。此举意味着，每25股现有普通股将合并为1股新股。反向股票分割通常旨在提高公司每股股价，以满足交易所的上市要求或改善其市场形象。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144332717","title":"Profusa股东在2026年年度会议上批准战略举措，支持Panomics收购、资产负债表强化及纳斯达克合规努力","url":"https://stock-news.laohu8.com/highlight/detail?id=1144332717","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144332717?lang=zh_cn&edition=full","pubTime":"2026-06-24 20:03","pubTimestamp":1782302600,"startTime":"0","endTime":"0","summary":"在2026年年度会议上，Profusa Inc的股东们正式批准了一系列关键战略举措。这些举措旨在支持公司对Panomics的收购计划，同时强化其资产负债表，并为满足纳斯达克市场的持续上市要求做出积极努力。\n股东们的支持为公司的战略方向提供了坚实后盾。收购Panomics预计将拓展Profusa在相关领域的业务版图与技术能力。而加强资产负债表则有助于提升公司的财务稳健性与灵活性，为未来增长奠定基础。此外，针对纳斯达克合规要求的持续努力，显示了公司致力于维持上市地位并遵守市场规则的决心。\n这一系列决议的通过，标志着Profusa在战略转型与公司治理方面迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145114765","title":"Profusa向Gmed提交回应文件 推进Lumee®氧气平台CE标志认证进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1145114765","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145114765?lang=zh_cn&edition=full","pubTime":"2026-06-12 20:03","pubTimestamp":1781265796,"startTime":"0","endTime":"0","summary":"Profusa公司已向Gmed提交了一份回应文件，作为其Lumee®氧气平台持续进行中的CE标志认证审查流程的一部分。此举标志着该创新医疗设备在获得欧洲市场准入许可的关键步骤中取得了新的进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PFSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149373510","title":"Profusa致信股东，力促在2026年6月23日的年度股东大会上对所有提案投赞成票","url":"https://stock-news.laohu8.com/highlight/detail?id=1149373510","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149373510?lang=zh_cn&edition=full","pubTime":"2026-06-10 20:01","pubTimestamp":1781092897,"startTime":"0","endTime":"0","summary":"Profusa Inc 近日向全体股东发布了一封公开信，强烈建议并鼓励股东在即将于2026年6月23日召开的年度股东大会上，对所有提交审议的公司提案投出赞成票。\n这封致股东信函的核心目的在于，确保公司关键的战略性议案能够获得必要的股东支持，从而顺利推进。公司管理层在信中阐述了各项提案对于Profusa未来长期发展、业务规划以及提升股东价值的重要性。他们呼吁股东积极参与投票，行使股东权利，共同支持公司的决策方向，以把握未来的增长机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102518557","title":"Profusa 向 Ascent Partners Fund 提交预先通知 拟通过股权额度协议购买股份 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1102518557","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102518557?lang=zh_cn&edition=full","pubTime":"2026-06-08 19:04","pubTimestamp":1780916654,"startTime":"0","endTime":"0","summary":"Profusa Inc 已根据相关证券协议，向 Ascent Partners Fund 提交了预先通知，计划依据一项股权额度安排进行股份购买。此举旨在为公司运营提供资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147765875","title":"Profusa Inc宣布启动战略评估：将探索资产层面交易、合作及并购等潜在机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=1147765875","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147765875?lang=zh_cn&edition=full","pubTime":"2026-05-05 20:33","pubTimestamp":1777984409,"startTime":"0","endTime":"0","summary":"生物传感技术企业Profusa Inc近日披露，公司正启动全面战略评估程序，旨在系统分析各类潜在发展机遇。评估范围涵盖资产层面交易、战略合作伙伴关系、业务合并以及其他可能的企业级交易方案。\n此次战略评估标志着Profusa Inc正积极寻求优化企业结构和资本配置，以提升长期价值创造能力。公司表示将审慎考察所有可行选项，确保决策符合股东利益最大化原则。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PFSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108740923","title":"Profusa Inc启动资产交易、合作伙伴关系、企业合并及其他公司交易评估流程","url":"https://stock-news.laohu8.com/highlight/detail?id=1108740923","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108740923?lang=zh_cn&edition=full","pubTime":"2026-05-05 20:31","pubTimestamp":1777984292,"startTime":"0","endTime":"0","summary":"生物科技公司Profusa Inc宣布正式启动针对资产收购、战略合作、企业合并及其他重大公司交易的评估程序。\n该评估机制将系统性地分析潜在交易机会，涵盖技术整合可行性、市场协同效应及财务影响等多维度考量。公司管理层表示，此举旨在优化资源配置，加速创新技术商业化进程。\n通过建立标准化评估框架，Profusa Inc将能够更高效地识别符合其长期发展战略的优质标的。该流程特别注重对知识产权价值、研发团队整合及监管合规性的综合评估。\n此次评估程序的规范化运作，标志着公司进入战略扩张的新阶段。未来将通过专业化团队对各类交易方案进行尽职调查与风险评估，确保决策的科学性与前瞻性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196578512","title":"Profusa启动董事会主导战略评估程序，旨在优化股东价值","url":"https://stock-news.laohu8.com/highlight/detail?id=1196578512","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196578512?lang=zh_cn&edition=full","pubTime":"2026-05-05 20:31","pubTimestamp":1777984277,"startTime":"0","endTime":"0","summary":"生物医学科技企业Profusa Inc宣布正式启动由董事会主导的战略评估程序。该举措旨在系统性地探索各类战略替代方案，以最大化公司股东价值。\n此次战略评估将全面考量包括但不限于业务合作、资本重组、资产优化等潜在路径。公司董事会表示，此决策基于对当前市场环境的审慎分析，以及对长期价值创造机遇的深入评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PFSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156475357","title":"Profusa启动董事会主导程序，评估战略选择以最大化股东价值","url":"https://stock-news.laohu8.com/highlight/detail?id=1156475357","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156475357?lang=zh_cn&edition=full","pubTime":"2026-05-05 20:31","pubTimestamp":1777984277,"startTime":"0","endTime":"0","summary":"Profusa Inc宣布正式启动由董事会主导的战略评估程序。此次行动旨在全面审视公司未来发展路径，通过系统化分析各类战略方案来优化股东回报。\n该评估流程将涵盖多项潜在战略选择，包括但不限于业务重组、资本运作及合作伙伴关系等可能性。公司董事会强调，此举是为了确保在快速变化的市场环境中把握最佳发展机遇。\nProfusa表示，战略评估委员会将由独立董事组成，确保决策过程的客观性与专业性。公司承诺将及时向投资者通报重要进展，同时保持与所有利益相关方的透明沟通。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174519209","title":"Profusa公司获3000万美元意向书，携泛组学平台进军价值数十亿美元精准诊断市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1174519209","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174519209?lang=zh_cn&edition=full","pubTime":"2026-04-06 18:01","pubTimestamp":1775469676,"startTime":"0","endTime":"0","summary":"Profusa公司宣布签署一份价值3000万美元的意向书，将正式进军规模达数十亿美元的精准诊断市场。此次战略布局的核心是公司开发的泛组学平台，该技术平台旨在通过多维度生物数据整合提升疾病诊断的精准度。此举标志着该公司在生命科学领域的业务拓展进入新阶段，有望在快速增长的精准医疗领域占据重要席位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PFSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160383899","title":"Profusa：预计自2026年第二季度起欧洲Lumee氧气产品收入将获得支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=1160383899","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160383899?lang=zh_cn&edition=full","pubTime":"2026-02-27 22:18","pubTimestamp":1772201894,"startTime":"0","endTime":"0","summary":"生物传感技术公司Profusa Inc宣布，其欧洲市场Lumee氧气监测产品的收入预期将从2026年第二季度开始获得实质性支撑。这一进展标志着公司在推进可植入式生物传感器商业化方面迈出关键一步，为未来业绩增长注入强心针。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFSA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.profusa.com","stockEarnings":[{"period":"1week","weight":0.517},{"period":"1month","weight":-0.2816},{"period":"3month","weight":-0.8549},{"period":"6month","weight":-0.9621},{"period":"1year","weight":-0.9984},{"period":"ytd","weight":-0.9931}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Profusa, Inc.于2021年4月19日作为特拉华州公司注册成立。该公司是一家数字健康技术公司，开发了一种皮下生物传感器平台Lumee，旨在提供实时的个体生物化学数据。其首款产品Lumee Oxygen已获得欧盟CE认证，同时公司正在开发用于糖尿病管理的Lumee Glucose。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.026744},{"month":2,"riseRate":0.8,"avgChangeRate":-0.161283},{"month":3,"riseRate":0.8,"avgChangeRate":-0.098641},{"month":4,"riseRate":0.8,"avgChangeRate":0.03957},{"month":5,"riseRate":0.4,"avgChangeRate":-0.071937},{"month":6,"riseRate":0.6,"avgChangeRate":-0.13244},{"month":7,"riseRate":0.2,"avgChangeRate":-0.312199},{"month":8,"riseRate":0.6,"avgChangeRate":-0.021696},{"month":9,"riseRate":0.75,"avgChangeRate":-0.065332},{"month":10,"riseRate":0.25,"avgChangeRate":-0.048336},{"month":11,"riseRate":0.75,"avgChangeRate":-0.068749},{"month":12,"riseRate":0.5,"avgChangeRate":-0.086317}],"exchange":"NASDAQ","name":"Profusa Inc","nameEN":"Profusa Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Profusa Inc(PFSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Profusa Inc(PFSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Profusa Inc,PFSA,Profusa Inc股票,Profusa Inc股票老虎,Profusa Inc股票老虎国际,Profusa Inc行情,Profusa Inc股票行情,Profusa Inc股价,Profusa Inc股市,Profusa Inc股票价格,Profusa Inc股票交易,Profusa Inc股票购买,Profusa Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Profusa Inc(PFSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Profusa Inc(PFSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}